by Diego Morales | Dec 17, 2024 | BayMedica, Uncategorized
The Benzinga Cannabis Capital Conference is one of the most influential events in the cannabis industry. As a leader in bringing together cannabis entrepreneurs, investors, thought leaders, and innovators, it provides an unmatched platform for networking, education,...
by Diego Morales | Dec 12, 2024 | BayMedica, Uncategorized
As the cannabinoid industry evolves, so does consumer demand for innovative and effective products. Ratio-based cannabinoid formulations, which combine two or more cannabinoids in specific ratios, are becoming a powerful way to target specific health and wellness...
by Diego Morales | Dec 5, 2024 | BayMedica, Uncategorized
The Rare Cannabinoid for Health and Wellness Cannabidivarin (CBDV) is quickly gaining attention in the cannabinoid industry for its unique properties and potential applications in health and wellness. This rare, non-intoxicating compound from the Cannabis sativa plant...
by Diego Morales | Dec 2, 2024 | BayMedica, Uncategorized
As consumer demand for rare cannabinoids like tetrahydrocannabivarin (THCV) rises, ensuring ingredient stability and quality becomes increasingly important. At BayMedica, we understand the unique challenges posed by buying, handling, and storing THCV—especially its...
by Diego Morales | Dec 2, 2024 | BayMedica, Uncategorized
In the rare cannabinoid industry, a common misconception persists: natural products are inherently purer and safer than their synthetic counterparts. This belief is especially common with rare cannabinoids like tetrahydrocannabivarin (THCV) or cannabichromene (CBC),...
by Diego Morales | Sep 27, 2024 | Uncategorized
In the rapidly evolving world of cannabinoid-based products, nature-identical synthesized cannabinoids are often misunderstood. As CPG product developers, understanding the facts behind these misconceptions can be crucial in making informed decisions that align with...
Recent Comments